Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NAP

Financiado

Cerrado

twiN on a chip brAins for monitoring individual sleeP habits

Insufficient sleep is an under-reported epidemic and sleep disturbances are common early signs of neurodegeneration. Clinical research is currently challenging the assumption that human sleep is a one-fits-all phenomenon: breaking... ver más

31/08/2026

Líder desconocido

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto Líder desconocido

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-12-16

HORIZON-EIC-2022-PATHFINDEROPEN-01-01: EIC Pathfinder Open 2022 Scope:You should apply to this call if you are looking for support from EIC Pathfinder Open to reali...

I+D

Cerrada

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 44 meses Fecha Inicio: 2022-12-16
Fecha Fin: 2026-08-31

Líder del proyecto Líder desconocido

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Insufficient sleep is an under-reported epidemic and sleep disturbances are common early signs of neurodegeneration. Clinical research is currently challenging the assumption that human sleep is a one-fits-all phenomenon: breaking new grounds into sleep research is needed. NAP makes real the study of individual sleep pathophysiology through a new science-to-technology paradigm merging in vitro modelling, allometric scaling, signal processing and micromanufacturing. NAP targets five breakthroughs: 1) the development of the first model enabling the accurate study of individual sleep, 2) the realization of the cyborganoid, i.e., the next generation of biohybrid model of the human brain, 3) the setup of an experimental procedure to mimic sleep in vitro accounting for a person’s lifestyle, metabolism and genetic makeup, 4) the exploitation of allometry to obtain meaningful information from in vitro to humans and 5) the delivery of the first tool for Parkinson’s Disease (PD) early diagnosis. As a Proof of Principle, NAP will identify the effects of sleep deprivation and detect sleep-related signs of PD in a personalised perspective. In the long-term, NAP will move Europe to lead sleep research and innovation through its envisioned technology: a predictive medicine twin-on-a-chip allowing the public at large to be routinely screened for i) checking their sleep health, ii) being warned about the consequences of sleep loss, iii) predating PD and other neuropathies characterized by sleep anomalies. This will be of benefit for science, society and economy. NAP Proof of Principle will deliver the first tool for accurately extrapolating biological parameters from in vitro to humans. The identification of individual sleep needs will allow the targeted detection of people suffering from sleep disorders, scaling back healthcare costs. Sleep-related neurodegeneration biomarkers will have tremendous implications in pharmacological research and enterprise and in the healthcare sector

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores